Antiphospholipase A2 Receptor Autoantibody Guided Diagnosis and Treatment of Membranous Nephropathy: A New Personalized Medical Approach-Reference-Cited by-同舟云学术

Antiphospholipase A2 Receptor Autoantibody Guided Diagnosis and Treatment of Membranous Nephropathy: A New Personalized Medical Approach

Published:2014-07-17 Issue:8 Volume:9 Page:1341-1343
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Glassock Richard J.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference19 articles.

1. Association of Anti-PLA2R Antibodies with Outcomes after Immunosuppressive Therapy in Idiopathic Membranous Nephropathy

2. M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy

3. Euroimmun US : FDA allows marketing of first non-invasive test to help in identifying cause of certain kidney disease. May 29, 2014. Available at http://www.euroimmun.us/fda-released/new-fda-release-pla2r-ifa. US Food and Drug Administration http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K132195. Both Accessed June 27, 2014

4. Phospholipase A2 Receptor Antibodies in Membranous Nephropathy: Unresolved Issues

5. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mannose-Binding Lectin Deposition in Membranous Nephropathy and Differentiation of Primary from Secondary Forms;International Journal of Molecular Sciences;2024-07-12

2. Diagnostic Usefulness of Antibodies Against M-type Phospholipase A2 Receptor (aPLA2R) in Primary Membranous Nephropathy in the Mexican Population;Cureus;2023-08-16

3. Clinical Application of M-Type Phospholipase A<sub>2</sub> Receptor in Idiopathic Membranous Nephropathy;Advances in Clinical Medicine;2023

4. The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice;International Journal of Environmental Research and Public Health;2022-04-27

5. Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer;Frontiers in Pharmacology;2022-01-17